Literature DB >> 33393053

Colorectal anastomosis during cytoreductive radical surgery in patients with peritoneal surface malignancies. Validation of a new technique (without stoma) to prevent anastomosis leakage in more than 1000 procedures.

P Barrios1,2, I Ramos3, O Crusellas3, D Sabia3, S Mompart3, M Martín-Baranera4,5.   

Abstract

OBJECTIVE: To describe a novel end-to-end "true" reinforced stapling colorectal anastomosis and to assess surgical outcomes in a large case series of advanced cancer patients undergoing this procedure. Anastomotic leakage (AL) remains the main concern following surgery for colorectal cancer.
METHODS: Between September 2006 and May 2018, in the context of the Catalonian Program of Peritoneal Carcinomatosis, 1193 consecutive patients with advanced abdominal and/or pelvic tumors were included in a prospective single-center study. They underwent cytoreductive radical surgery (CRS) in most cases combined with hyperthermic intraperitoneal chemotherapy (HIPEC). Among other surgical procedures, 374 patients underwent rectal resection and colorectal/ileorectal anastomosis, whether alone or associated to other digestive anastomosis. Key aspects of colorectal anastomosis technique were: (1) complete dissection and mobilization of the distal third of the rectum, (2) placement of a stitch that included both ends of the linear stapling of the rectal stump that was knotted on the anvil of the circular stapler, (3) "cleaning" the fatty tissue of the intestinal ends, (4) adjustment of the height of staples to the thickness of the intestinal wall, and (5) a second layer of interrupted nonperforating sutures placed circumferentially to reinforce the stapled anastomoses. A diverting stoma was not performed.
RESULTS: According to clinical criteria, of the 1193 patients included, 296 cases underwent CRS (group 1) and 897 cases CRS + HIPEC (group 2). In group 1, 332 surgical procedures were performed, with 248 digestive anastomoses, of which 98 (39.5%) were colorectal anastomoses, associated to other digestive anastomosis in 37 cases. In group 2, 972 surgical procedures were performed, with 707 digestive anastomoses, of which 263 were colorectal (37.2%), 116 were associated with other digestive anastomosis. Ileocolic anastomosis was the most frequently associated digestive anastomosis. 71 major urinary reconstructions, 283 radical hysterectomies and no diverting stoma were performed. Globally, there was only three colo-ileorectal AL (3/374 = 0.8%). The overall 90-day mortality rate was 0.25%.
CONCLUSIONS: A technical modification to create a "true" end-to-end and completely circular reinforced anastomosis effectively prevents anastomotic leakage in patients with advanced tumors undergoing radical resection of the rectum, with no need of diverting stoma.

Entities:  

Keywords:  Colorectal anastomoses; Colorectal anastomotic leakage; Colorectal surgery; Digestive complications of cytoreductive radical surgery and hyperthermic intraperitoneal chemotherapy (CRS + HIPEC); Peritoneal metastasis

Mesh:

Year:  2021        PMID: 33393053     DOI: 10.1007/s12094-020-02511-7

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  38 in total

1.  Anastomotic leakage and functional outcome after anterior resection of the rectum.

Authors:  O Hallböök; R Sjödahl
Journal:  Br J Surg       Date:  1996-01       Impact factor: 6.939

2.  Risk factors and outcomes for anastomotic leakage in colorectal surgery: a single-institution analysis of 1576 patients.

Authors:  Mark A Boccola; Petra G Buettner; Warren M Rozen; Simon K Siu; Andrew R L Stevenson; Russell Stitz; Yik-Hong Ho
Journal:  World J Surg       Date:  2011-01       Impact factor: 3.352

3.  Factors associated with clinically significant anastomotic leakage after large bowel resection: multivariate analysis of 707 patients.

Authors:  Arnaud Alves; Yves Panis; Danielle Trancart; Jean-Marc Regimbeau; Marc Pocard; Patrice Valleur
Journal:  World J Surg       Date:  2002-02-04       Impact factor: 3.352

4.  Risk factors for colorectal anastomotic stenoses and their impact on quality of life: what are the lessons to learn?

Authors:  L Polese; M Vecchiato; A C Frigo; G Sarzo; R Cadrobbi; R Rizzato; A Bressan; S Merigliano
Journal:  Colorectal Dis       Date:  2012-03       Impact factor: 3.788

5.  Long-term prospective assessment of functional results after proctectomy with coloanal anastomosis.

Authors:  A Fichera; F Michelassi
Journal:  J Gastrointest Surg       Date:  2001 Mar-Apr       Impact factor: 3.452

Review 6.  Systematic review of the technique of colorectal anastomosis.

Authors:  Juliette C Slieker; Freek Daams; Irene M Mulder; Johannes Jeekel; Johan F Lange
Journal:  JAMA Surg       Date:  2013-02       Impact factor: 14.766

7.  End-to-end versus end-to-side stapled anastomoses after anterior resection for rectal cancer.

Authors:  Giuseppe Brisinda; Serafino Vanella; Federica Cadeddu; Ignazio Massimo Civello; Francesco Brandara; Casimiro Nigro; Pasquale Mazzeo; Gaia Marniga; Giorgio Maria
Journal:  J Surg Oncol       Date:  2009-01-01       Impact factor: 3.454

8.  Cost-effectiveness of defunctioning stomas in low anterior resections for rectal cancer: a call for benchmarking.

Authors:  Thomas Koperna
Journal:  Arch Surg       Date:  2003-12

9.  Anastomotic leakage is predictive of diminished survival after potentially curative resection for colorectal cancer.

Authors:  Kenneth G Walker; Stephen W Bell; Matthew J F X Rickard; Daniel Mehanna; Owen F Dent; Pierre H Chapuis; E Leslie Bokey
Journal:  Ann Surg       Date:  2004-08       Impact factor: 12.969

10.  Impact of anastomotic leakage on oncological outcome after rectal cancer resection.

Authors:  H Ptok; F Marusch; F Meyer; D Schubert; I Gastinger; H Lippert
Journal:  Br J Surg       Date:  2007-12       Impact factor: 6.939

View more
  1 in total

1.  Safe Anastomoses without Ostomies in Cytoreductive Surgery with Heated Intraperitoneal Chemotherapy: Technical Considerations and Modifications.

Authors:  Pedro Barrios; Isabel Ramos; Oriol Crusellas; Domenico Sabia; Sergio Mompart; Lana Bijelic
Journal:  Ann Surg Oncol       Date:  2021-04-14       Impact factor: 5.344

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.